Cargando…
New Immunotherapy Strategies in Breast Cancer
Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295319/ https://www.ncbi.nlm.nih.gov/pubmed/28085094 http://dx.doi.org/10.3390/ijerph14010068 |
_version_ | 1782505412028792832 |
---|---|
author | Yu, Lin-Yu Tang, Jie Zhang, Cong-Min Zeng, Wen-Jing Yan, Han Li, Mu-Peng Chen, Xiao-Ping |
author_facet | Yu, Lin-Yu Tang, Jie Zhang, Cong-Min Zeng, Wen-Jing Yan, Han Li, Mu-Peng Chen, Xiao-Ping |
author_sort | Yu, Lin-Yu |
collection | PubMed |
description | Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy becomes a promising new field in breast cancer therapies. In this review, we discussed recent progress in breast cancer immunotherapy, including cancer vaccines, bispecific antibodies, and immune checkpoint inhibitors. Several additional immunotherapy modalities in early stages of development are also highlighted. It is believed that these new immunotherapeutic strategies will ultimately change the current status of breast cancer therapies. |
format | Online Article Text |
id | pubmed-5295319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-52953192017-02-07 New Immunotherapy Strategies in Breast Cancer Yu, Lin-Yu Tang, Jie Zhang, Cong-Min Zeng, Wen-Jing Yan, Han Li, Mu-Peng Chen, Xiao-Ping Int J Environ Res Public Health Review Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy becomes a promising new field in breast cancer therapies. In this review, we discussed recent progress in breast cancer immunotherapy, including cancer vaccines, bispecific antibodies, and immune checkpoint inhibitors. Several additional immunotherapy modalities in early stages of development are also highlighted. It is believed that these new immunotherapeutic strategies will ultimately change the current status of breast cancer therapies. MDPI 2017-01-12 2017-01 /pmc/articles/PMC5295319/ /pubmed/28085094 http://dx.doi.org/10.3390/ijerph14010068 Text en © 2017 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Yu, Lin-Yu Tang, Jie Zhang, Cong-Min Zeng, Wen-Jing Yan, Han Li, Mu-Peng Chen, Xiao-Ping New Immunotherapy Strategies in Breast Cancer |
title | New Immunotherapy Strategies in Breast Cancer |
title_full | New Immunotherapy Strategies in Breast Cancer |
title_fullStr | New Immunotherapy Strategies in Breast Cancer |
title_full_unstemmed | New Immunotherapy Strategies in Breast Cancer |
title_short | New Immunotherapy Strategies in Breast Cancer |
title_sort | new immunotherapy strategies in breast cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295319/ https://www.ncbi.nlm.nih.gov/pubmed/28085094 http://dx.doi.org/10.3390/ijerph14010068 |
work_keys_str_mv | AT yulinyu newimmunotherapystrategiesinbreastcancer AT tangjie newimmunotherapystrategiesinbreastcancer AT zhangcongmin newimmunotherapystrategiesinbreastcancer AT zengwenjing newimmunotherapystrategiesinbreastcancer AT yanhan newimmunotherapystrategiesinbreastcancer AT limupeng newimmunotherapystrategiesinbreastcancer AT chenxiaoping newimmunotherapystrategiesinbreastcancer |